AFT Pharmaceuticals (NZX:AFT)
ASX announcement history & article coverage
Transparent by design.
Announcments by AFT Pharmaceuticals (NZX:AFT) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
AFT reports ongoing sales growth and R&D progress
AFT Notice of Meeting 2026 Proxy Form
AFT Notice of Meeting of Shareholders 2026
FDA allows AFT’s injectable iron project clinical study
AFT Pharmaceuticals FY26 revenue up 22%, targets $300M in FY27 with global expansion and R&D progress
capital change notice
Annual Meeting and Closing Date for Director Nominations
issue of unlisted options
FY26 dividend distribution notice
AFT Pharmaceuticals declares fully imputed final dividend of NZD 2.62 million for FY2026
AFT delivers double digit revenue growth and record earnings
AFT Pharmaceuticals posts record FY26 profit, targets $300M+ revenue in FY27
FY26 App2
AFT Pharmaceuticals posts 22% revenue growth and 23% profit increase for FY2026, declares final dividend
FY26 Presentation
AFT Pharmaceuticals FY26 revenue up 22%, targets NZ$300m in FY27 with strong international expansion and R&D pipeline
FY26 Annual Report
AFT Pharmaceuticals posts record FY26 profit, expands global reach, boosts R&D, targets $300m revenue in FY27
AFT Pharmaceuticals names Stuart Houliston CFO
AFT Pharmaceuticals to announce full year results on Thursday May 21 2026
AFT Pharmaceuticals to release FY2026 results on May 21 with management webinar